China blocks GSK from participating in national bulk-buy pharmaceutical
program
Send a link to a friend
 [October 31, 2022]
BEIJING (Reuters) - China has
blocked GSK plc from participating in its national bulk-buy
pharmaceutical program from Oct. 31, 2022 to April 29, 2024 due to what
it said were recent drug product irregularities, state television CCTV
reported on Monday. (Reporting by Beijing newsroom; editing by Philippa Fletcher)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
GSK (GlaxoSmithKline) logo is seen in
this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration
 |
